Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

Maurice B Bizino; Ingrid M Jazet; Jos J M Westenberg; Huub J van Eyk; Elisabeth H M Paiman; Jan W A Smit; Hildebrandus J Lamb

doi:10.1186/s12933-019-0905-2

Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

Cardiovasc Diabetol. 2019 Aug 9;18(1):101. doi: 10.1186/s12933-019-0905-2.

Authors

Maurice B Bizino¹, Ingrid M Jazet², Jos J M Westenberg³, Huub J van Eyk², Elisabeth H M Paiman³, Jan W A Smit⁴, Hildebrandus J Lamb³

Affiliations

¹ Department of Radiology, Leiden University Medical Center, LUMC postzone C2S, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. [email protected].
² Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands.
³ Department of Radiology, Leiden University Medical Center, LUMC postzone C2S, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
⁴ Department of Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Abstract

Following publication of the original article [1], the authors reported an error in Fig. 3. The bars in the upper right panel that represent heart rate in placebo treated patients is not correct.

Publication types

Published Erratum